Mesoblast Ltd is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MEOBF is expected to report earnings to rise 56.00% to -2 cents per share on May 29
Q1'24
Est.
$-0.02
Q4'24
Est.
$-0.01
Q3'24
Est.
$-0.01
Q4'23
Est.
$-0.02
Q3'23
Est.
$-0.02
The last earnings report on February 26 showed earnings per share of -1 cents, meeting the estimate of -1 cents. With 135.00 shares outstanding, the current market capitalization sits at 1.22B.